Clinical characteristics and disease burden of patients with diabetes mellitus combined with cardiovascular or chronic kidney disease based on regional medical database in Tianjin China

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/41784
• EU PAS number:
  EUPAS38023
• Study ID:
  41784
• Official title and acronym:
  Clinical characteristics and disease burden of patients with diabetes mellitus combined with cardiovascular or chronic kidney disease based on regional medical database in Tianjin China
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  The study aims to investigate the clinical characteristics, treatment, and economic burden of disease of Chinese diabetic/non-diabetic patients with/without established cardiovascular disease, chronic kidney disease, or at high cardiovascular risk, including: Primary objectives: describe the proportion of Chinese diabetic/non-diabetic patients with established cardiovascular disease, CKD, or at high cardiovascular risk including hypertension and hyperlipidemia, Secondary objectives: describe the demographic characteristics of the last visit for all patients, and the demographic characteristics of inpatients over time, investigate the clinical characteristic for all patients
• Study status:
  Planned

Research institutions and networks

Institutions

West China Hospital

Study timelines

Date when funding contract was signed

Planned: 01/12/2020

Actual: 27/11/2020

Study start date

Planned: 20/07/2021

Data analysis start date

Planned: 01/09/2021

Date of final study report

Planned: 30/11/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable